The shingles vaccine given to people in Britain could delay the onset of dementia, according to a new study.
The finding, which experts say is “convincing”, shows that the adjuvanted recombinant zoster vaccine is linked to at least a 17% drop in dementia diagnoses in the six years after vaccination than the previously-used live zoster vaccine.
Already a subscriber? Log in
Get 20% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
